BioSpace News Archive

Oxurion NV, a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, announced a restructuring plan to better align resources towards executing its clinical development strategy, including advancing its two novel programs, THR-687 and THR-149.

Oral rehydration salt (ORS) is a glucose-based salt solution used for oral rehydration therapy, which is recommended by the United Nations Children’s Fund and the World Health Organization (WHO) for use in the treatment or prevention of dehydration caused by diarrhea.

The global cystatin C testing market is poised to grow at stupendous pace during the forecast period of 2019 to 2027.

Sanofi announced today that its Q2 2021 Memorandum for modelling purposes is available on the “Investors” page of the company’s website

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Commission has approved the PD-1 inhibitor Libtayo® to treat adults with locally advanced or metastatic basal cell carcinoma who have progressed on or are intolerant to a hedgehog pathway inhibitor.

InxMed Co., Ltd. announced one study in collaboration with Ruijin Hospital, Shanghai Jiaotong University School of Medicine made an online publication on Advanced Science titled “Focal Adhesion Kinase Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling”.

Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd showcased its lineup of COVID-19 testing solutions and its point-of-care testing in vitro diagnostic instruments at the 2021 Medlab Middle East, an industry-leading medical laboratory exhibition co-located with Arab Health that was held from 21 to 24 June, 2021 in the Dubai World Trade Centre, UAE.